http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b60d6e7594e976035fc639aa04652715
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Guan |
| name | Xiaoxiang Guan |
| given-name | Xiaoxiang |
| organization-name | Department of Medical Oncology Jinling Hospital Medical School of Nanjing University Nanjing China; Department of Epidemiology The University of Texas MD Anderson Cancer Center Houston TX USA Department of Medical Oncology Department of Medical Oncology, Jinling Hospital, School of Medicine, Southern Medical University, Guangzhou, China; Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China Department of Oncology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. Department of Medical Oncology; Jinling Hospital; School of Medicine; Southern Medical University; Guangzhou P.R. China; Department of Medical Oncology; Jinling Hospital; Medical School of Nanjing University; Nanjing P.R. China Department of Medical Oncology, Jinling Hospital, Southern Medical University, Guangzhou, China.; Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. Department of Medical Oncology Jinling Hospital, Nanjing University School of Medicine Nanjing China; Department of Epidemiology The University of Texas M. D. Anderson Cancer Center Houston TX USA Department of Medical OncologyJinling HospitalMedical School of Nanjing UniversityNanjingChina; Department of EpidemiologyThe University of Texas M. D. Anderson Cancer CenterHoustonTexasUSA Department of Oncology, Jiangsu Province Hospital, Nanjing, Jiangsu 210029, People’s Republic of China Authors' Affiliations: Departments of 1Epidemiology, and 2Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 3Department of Clinical Oncology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu Province, P.R. China; and 4Department of Otolaryngology, Qilu Hospital, Shandong University; Key Laboratory of Otolaryngology, Ministry of Health, Jinan, Shandong, P.R. China; Authors' Affiliations: Departments of 1Epidemiology, and 2Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 3Department of Clinical Oncology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu Province, P.R. China; and 4Department of Otolaryngology, Qilu Hospital, Shandong University; Key Laboratory of Otolaryngology, Ministry of Health, Jinan, Shandong, P.R. China From the Institute of Reproductive Medicine (Y.Y.C., X.H.W., Q.C.), Nanjing Medical University; Atherosclerosis Research Center, Key Laboratory of Human Functional Genomics (Y.Y.C., X.H.W., J.J.B., S.Y., H.B., X.X.G., X.M.B., L.J., Y.J., L.M.F., Q.C.), Nanjing Medical University, Nanjing, People’s Republic of China. Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing 210029, China Department of Medical Oncology; Jinling Hospital; Southern Medical University; 305 East Zhongshan Road, Nanjing Jiangsu Province P.R. China Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China Department of Pharmacology; Jinling Hospital; Medical School of Nanjing University; Nanjing 210002; China Department of Medical Oncology Jinling Hospital, Nanjing University School of Medicine Nanjing China Department of Oncology, The First Affiliated Hospital of Nanjing Medical University Nanjing 210029, China. Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, China. Department of Oncology Jinling Hospital, Nanjing University School of Medicine Nanjing China Department of Medical Oncology, Jinling Hospital, School of Medicine, Southern Medical University, Guangzhou, P.R. China; Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, P.R. China Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing Medical University, Nanjing, China Atherosclerosis Research Center, Nanjing Medical University, Nanjing, Jiangsu, 210029 P. R. China. lmfan@njmu.edu.cn Department of Medical Oncology Jinling Hospital Medical School of Nanjing University Nanjing China; Department of Medical Oncology Jinling Hospital School of Medicine Southern Medical University Guangzhou China Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China Department of Oncology The First Affiliated Hospital of Nanjing Medical University Nanjing China Department of Medical Oncology, Jinling Hospital, School of Medicine, Southern Medical University, Guangzhou, P.R. China.; Department of Medical Oncology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, P.R. China. Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, P.R. China. Department of Epidemiology The University of Texas M.D. Anderson Cancer Center Houston Texas; Department of Medical Oncology Jinling Hospital, Nanjing University School of Medicine Jiangsu China Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China (mainland) Medical School of Nanjing University, Nanjing, China; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China Jinling Clinical Medical College, Nanjing Medical University, Nanjing 210002, China. xxguan@hotmail.com. Department of Medical Oncology Jinling Hospital, Nanjing University School of Medicine 305 East Zhongshan Road, Nanjing, Jiangsu 210002 China Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China; Department of Medical Oncology, Jinling Hospital, School of Medicine, Southern Medical University, Guangzhou 510282, China Department of Medical OncologyJinling Hospital, Nanjing Medical University Nanjing China; Department of Medical OncologyJinling Hospital, Medical School of Nanjing University Nanjing China Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, P.R. China Department of Oncology The First Affiliated Hospital of Nanjing Medical University Nanjing 210029 China Department of Oncology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, 210000 Nanjing, China; |
Incoming Links
Total number of triples: 172.